{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:39:09Z","timestamp":1788565149056,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":4482,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.exphem.2009.12.004","type":"journal-article","created":{"date-parts":[[2009,12,25]],"date-time":"2009-12-25T04:11:07Z","timestamp":1261714267000},"page":"202-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Abnormalities of the \u03b1\u03b2 T-cell receptor repertoire in advanced myelodysplastic syndrome"],"prefix":"10.1016","volume":"38","author":[{"given":"Paulo V.","family":"Campregher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Joachim","family":"Deeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan S.","family":"Robins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edus H.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2009.12.004_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2141.1998.00551.x","article-title":"Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow","volume":"100","author":"Jonasova","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2009.12.004_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0145-2126(03)00008-0","article-title":"Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan","volume":"27","author":"Shimamoto","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2009.12.004_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-2141.1997.4423249.x","article-title":"Antithymocyte globulin for patients with myelodysplastic syndrome","volume":"99","author":"Molldrem","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2009.12.004_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1046\/j.1365-2141.1998.00920.x","article-title":"Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles","volume":"102","author":"Molldrem","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2009.12.004_bib5","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood.V100.5.1570.h81702001570_1570_1574","article-title":"HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and\u00a0predicts a response to immunosuppression in myelodysplastic syndrome","volume":"100","author":"Saunthararajah","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib6","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2002-01-0155","article-title":"Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression","volume":"100","author":"Kochenderfer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2141.2003.04136.x","article-title":"A pilot study of antithymocyte globulin (ATG) in the treatment of patients with \u2018low-risk\u2019 myelodysplasia","volume":"120","author":"Killick","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2009.12.004_bib8","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/sj.leu.2403124","article-title":"Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes","volume":"17","author":"Yazji","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2009.12.004_bib9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.leu.2403239","article-title":"A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes","volume":"18","author":"Stadler","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2009.12.004_bib10","first-page":"667","article-title":"Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes","volume":"91","author":"Broliden","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2009.12.004_bib11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.leukres.2004.03.016","article-title":"Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells","volume":"28","author":"Deeg","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2009.12.004_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0145-2126(91)90028-R","article-title":"The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study","volume":"15","author":"Smith","year":"1991","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2009.12.004_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ajh.2830410425","article-title":"T cell-mediated inhibition of erythropoiesis in myelodysplastic syndromes","volume":"41","author":"Sugawara","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2009.12.004_bib14","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0301-472X(02)00968-2","article-title":"Autologous lymphocytes inhibit hemopoiesis in long-term culture in patients with myelodysplastic syndrome","volume":"30","author":"Baumann","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.12.004_bib15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood-2004-05-2017","article-title":"Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome","volume":"106","author":"Sloand","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0145-2126(01)00083-2","article-title":"Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process","volume":"25","author":"Epperson","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2009.12.004_bib17","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood-2005-09-3902","article-title":"Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome","volume":"108","author":"Wlodarski","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib18","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0301-472X(01)00736-6","article-title":"Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia","volume":"29","author":"Kook","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.12.004_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2141.2002.03802.x","article-title":"Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome","volume":"119","author":"Melenhorst","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2009.12.004_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.leu.2404590","article-title":"Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome","volume":"21","author":"Epling-Burnette","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2009.12.004_bib21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.exphem.2009.04.009","article-title":"Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset","volume":"37","author":"Fozza","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2009.12.004_bib22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1084\/jem.179.2.609","article-title":"Clonal populations of T cells in normal elderly humans: the T cell equivalent to \u201cbenign monoclonal gammapathy\u201d","volume":"179","author":"Posnett","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2009.12.004_bib23","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.4049\/jimmunol.158.9.4493","article-title":"Expanded CD4+ and CD8+ T cell clones in elderly humans","volume":"158","author":"Schwab","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2009.12.004_bib24","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.4049\/jimmunol.174.11.7446","article-title":"The influence of age on T cell generation and TCR diversity","volume":"174","author":"Naylor","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2009.12.004_bib25","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.4049\/jimmunol.169.4.1984","article-title":"Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals","volume":"169","author":"Khan","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2009.12.004_bib26","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib27","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V99.3.840","article-title":"Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients","volume":"99","author":"Onida","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib29","first-page":"926","article-title":"Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia","volume":"89","author":"Barragan","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2009.12.004_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.exphem.2009.12.004_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1034\/j.1399-0039.1999.530202.x","article-title":"Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: application for assessment of clonal composition","volume":"53","author":"Akatsuka","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.exphem.2009.12.004_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2141.2003.04036.x","article-title":"Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantation","volume":"120","author":"Peggs","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2009.12.004_bib33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1126\/science.7535476","article-title":"Antigen-specific development of primary and memory T cells in vivo","volume":"268","author":"McHeyzer-Williams","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.exphem.2009.12.004_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1109\/TNN.2005.845141","article-title":"Survey of clustering algorithms","volume":"16","author":"Xu","year":"2005","journal-title":"IEEE Trans Neural Netw"},{"key":"10.1016\/j.exphem.2009.12.004_bib35","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/blood.V99.10.3668","article-title":"Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens","volume":"99","author":"Kook","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib36","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1182\/blood-2002-01-0096","article-title":"Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities","volume":"100","author":"Sloand","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.molimm.2006.06.026","article-title":"Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biases","volume":"44","author":"Miqueu","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.exphem.2009.12.004_bib38","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/cncr.22570","article-title":"Myelodysplastic syndromes: incidence and survival in the United States","volume":"109","author":"Ma","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2009.12.004_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2008-01-134858","article-title":"Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs","volume":"112","author":"Rollison","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib40","first-page":"662","article-title":"Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology","volume":"10","author":"Bernell","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2009.12.004_bib41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.leu.2401341","article-title":"The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes","volume":"13","author":"Tamaki","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2009.12.004_bib42","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1200\/JCO.2003.10.503","article-title":"Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes","volume":"21","author":"Cilloni","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.exphem.2009.12.004_bib43","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1182\/blood.V99.9.3272","article-title":"Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies","volume":"99","author":"Elisseeva","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib44","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/blood.V96.4.1480","article-title":"Immunity to WT1 in the animal model and in patients with acute myeloid leukemia","volume":"96","author":"Gaiger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/sj.leu.2403539","article-title":"Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies","volume":"19","author":"Wu","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2009.12.004_bib46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2007-08-108241","article-title":"Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies","volume":"111","author":"Rezvani","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib47","doi-asserted-by":"crossref","unstructured":"Holsinger AL, Ramakrishnan A, Storer B, et\u00a0al. Therapy of myelodysplastic syndrome (MDS) with azacitidine given in combination with etanercept: a phase II study. Blood (ASH Annual Meeting Abstracts). 2007;110:Abstract 1452.","DOI":"10.1182\/blood.V110.11.1452.1452"},{"key":"10.1016\/j.exphem.2009.12.004_bib48","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1182\/blood-2002-11-3458","article-title":"5-Aza-2'-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach?","volume":"101","author":"Sigalotti","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib49","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1182\/blood-2007-07-103960","article-title":"Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia","volume":"111","author":"Oki","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2009.12.004_bib50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1101\/gr.073262.107","article-title":"The new paradigm of flow cell sequencing","volume":"18","author":"Holt","year":"2008","journal-title":"Genome Res"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X09004615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X09004615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:28:03Z","timestamp":1759566483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X09004615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0301472X09004615"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2009.12.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormalities of the \u03b1\u03b2 T-cell receptor repertoire in advanced myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2009.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}